Table 1 Clinical features of UTROSCT patients
Case | Age | Menopausal status | Parity | Symptoms | Tumor position | Tumor biomarkers | Treatment approaches | Recurrence | ||
|---|---|---|---|---|---|---|---|---|---|---|
CA199 U/ml | CEA ng/ml | CA125 U/ml | ||||||||
1 | 39 | No | 2–0-0–2 | Vaginal bleeding | Submucosa (myometrium) | 13.61 | 2.59 | 9.06 | Mass resection | No (1 month) |
2 | 34 | No | 1–0-0–1 | Menstrual disorder | Submucosa (myometrium) |  −  | NA | NA | Mass resection | No (2 months) |
3 | 29 | No | 1–0-1–1 | No symptoms | Submucosa (myometrium) |  −  | NA | NA | Mass resection | No (54 months) |
4 | 40 | No | 0–0-0–0 | No symptoms | Endometrium | 9.39 | NA | 23 | Hysterectomy | No (24 months) |
5 | 67 | Yes | 2–0-0–2 | Vaginal bleeding | Submucosa (myometrium) | 17.72 | 2.5 | 6.64 | Hysterectomy | No (5 months) |
6 | 53 | No | 2–0-0–2 | Vaginal bleeding | Endometrium | 6.64 | 1.49 | 12.44 | Hysterectomy | No (6 months) |
7 | 55 | Yes | 2–0-1–2 | Vaginal bleeding | Submucosa (myometrium) | NA | NA | NA | Hysterectomy | No (66 months) |
8 | 70 | Yes | 5–0-1–5 | Vaginal bleeding | Submucosa (myometrium) | NA | NA | NA | Hysterectomy | No (125 months) |
9 | 52 | Yes | 2–0-0–2 | Vaginal bleeding | Endometrium | 14.64 | 2 | 8 | Hysterectomy | No (29 months) |
10 | 57 | Yes | 3–0-0–3 | Vaginal secretion | Endometrium | NA | NA | NA | Radical surgery | No (31 months) |
11 | 59 | Yes | 2–0-0–2 | Vaginal bleeding | Submucosa (myometrium) | - | 1.54 | NA | Radical surgery | No (13 months) |